Trial ID | Outcome | High risk of bias (category A)a | High risk of bias (category D)b | High risk of bias (category E)c | High risk of bias (category G)d |
Ensor 2015 | Body weight | Yes | No | No | No |
Anthropometric measures other than body weight (kg) | Yes | No | No | No | |
Barriocanal 2008 | Body weight | Yes | No | No | No |
Anthropometric measures other than body weight (kg) | Yes | No | No | No | |
Maki 2008 | NA | ||||
Grotz 2003 | HbA1c | Yes | No | No | No |
Adverse events | Yes | No | No | No | |
Colagiuri 1989 | NA | ||||
Cooper 1988 | NA | ||||
Chantelau 1985 | NA | ||||
Nehrling 1985 | NA | ||||
Stern 1976 | Glucose levels, fasting | No | No | Yes | No |
aClear that outcome was measured and analysed; trial report stated that outcome was analysed but reported only that result was not significant (Classification 'A', table 2, Kirkham 2010).
bClear that outcome was measured and analysed; trial report stated that outcome was analysed but reported no results ( Classification 'D', table 2, Kirkham 2010).
cClear that outcome was measured but was not necessarily analysed; judgement says likely to have been analysed but not reported because of non‐significant results (Classification 'E', table 2, Kirkham 2010).
dUnclear whether outcome was measured; not mentioned, but clinical judgement says likely to have been measured and analysed but not reported on the basis of non‐significant results (Classification 'G', table 2, Kirkham 2010). HbA1c: glycosylated haemoglobin A1c; NA: not applicable. |